LIOPYLIOPYOTC
Loading
EBITDA Over TimeStable
Percentile Rank93
3Y CAGR+3.5%
5Y CAGR-0.7%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+3.5%/yr
vs +6.8%/yr prior
5Y CAGR
-0.7%/yr
Recent acceleration
Acceleration
-3.4pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive growthStable
PeriodValueYoY Change
2025$54.40B+0.3%
2024$54.22B+24.9%
2023$43.42B-11.6%
2022$49.14B+1.4%
2021$48.48B-14.0%
2020$56.37B+34.0%
2019$42.07B+11.5%
2018$37.75B-5.6%
2017$39.98B+15.4%
2016$34.65B-